BRENNER RANDALL B. (Chief Development & Regulatory) sold 8.3% of their position (29.28K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $57.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/14/2022ACC: 0000904454-22-000623
Officer· Chief Development & Regulatory
Since Sep 2019
-29.28K
Net shares
Net seller
$57.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
29.28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−11.11K
Price / share
$1.98
Trade value
$21.99K
% of position
3.1%
12/12/2022
354.13K→343.03K
Common Stock
Direct
Shares
−18.18K
Price / share
$1.96
Trade value
$35.63K
% of position
5.3%
12/13/2022
343.03K→324.85K
Total
Net shares
−29.28K
Net value
-$57.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2022 | S · Sale | −11.11K | $1.98 | $21.99K | 3.1% | 354.13K | 343.03K |
| Common Stock Direct | 12/13/2022 | S · Sale | −18.18K | $1.96 | $35.63K | 5.3% | 343.03K | 324.85K |
| Total | −29.28K | -$57.61K | ||||||
Derivative Transactions0
No derivative transactions reported